Fmr LLC Purchases 111,086 Shares of Teleflex Incorporated (NYSE:TFX)

FMR LLC lifted its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 70.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 269,490 shares of the medical technology company's stock after purchasing an additional 111,086 shares during the quarter. FMR LLC owned about 0.58% of Teleflex worth $66,650,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund grew its stake in shares of Teleflex by 1.2% during the second quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company's stock valued at $846,000 after buying an additional 46 shares during the last quarter. Cromwell Holdings LLC grew its stake in shares of Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock valued at $33,000 after buying an additional 49 shares during the last quarter. Crossmark Global Holdings Inc. grew its stake in shares of Teleflex by 1.9% during the second quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company's stock valued at $584,000 after buying an additional 53 shares during the last quarter. Apollon Wealth Management LLC grew its stake in shares of Teleflex by 3.7% during the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company's stock valued at $377,000 after buying an additional 55 shares during the last quarter. Finally, SRS Capital Advisors Inc. grew its stake in shares of Teleflex by 0.3% during the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company's stock valued at $4,844,000 after buying an additional 60 shares during the last quarter. Institutional investors own 95.62% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on TFX shares. Mizuho dropped their target price on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, November 1st. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a report on Friday, November 1st. Truist Financial reiterated a "hold" rating and set a $227.00 target price (down from $255.00) on shares of Teleflex in a report on Monday, November 4th. Royal Bank of Canada dropped their target price on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Finally, StockNews.com upgraded shares of Teleflex from a "hold" rating to a "buy" rating in a report on Thursday, November 28th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $259.00.

Teleflex Stock Down 1.0 %

TFX traded down $1.82 on Friday, hitting $184.65. The company had a trading volume of 270,563 shares, compared to its average volume of 461,568. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a 52-week low of $184.23 and a 52-week high of $257.85. The stock has a fifty day simple moving average of $214.17 and a 200-day simple moving average of $221.36. The firm has a market capitalization of $8.58 billion, a P/E ratio of 36.71, a P/E/G ratio of 1.92 and a beta of 1.16.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping the consensus estimate of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. During the same period last year, the business posted $3.64 earnings per share. Teleflex's quarterly revenue was up 2.4% compared to the same quarter last year. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex's dividend payout ratio is 27.04%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.